🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo pMDI

Found 67 matching trials

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

PHASE3

The purpose of this study is to compare the efficacy and safety of the fixe...

Status

Completed

Location

Research Center

Start Date

2006-06

Trial ID

NCT00393952

Treatments Being Tested

Fluticasone propionate/Formoterol fumarate 250/10 Placebo Fluticasone propionate/Formoterol fumarate 100/10 Fluticasone propionate 250 Formoterol fumarate 10

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

PHASE1

The purpose of this study is to evaluate the safety and the efficacy of Gly...

Status

Completed

Location

Medicines Evaluation Unit

Start Date

2010-08

Trial ID

NCT01176903

Treatments Being Tested

Glycopyrrolate Tiotropium placebo

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men

PHASE1

This is a randomized, single-blind, placebo-controlled, sequential-group st...

Status

Completed

Location

Research Site

Start Date

2016-01-12

Trial ID

NCT02645253

Treatments Being Tested

AZD7594 inhalation powder (200 μg)AZD7594 inhalation powder (400 μg)AZD7594 pressurized inhalation suspension (200 μg)AZD7594 placebo inhalation powder AZD7594 placebo pressurized inhalation suspension

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

PHASE2

The purpose of this study is to evaluate the efficacy of Fixed Combination ...

Status

Completed

Location

Medical Center Convex EOOD

Start Date

2018-06-15

Trial ID

NCT03590379

Treatments Being Tested

CHF 5993 DPI CHF5993 pMDI CHF 1535 pMDI Placebo DPI Placebo pMDI

Symbicort Onset of Action 1

PHASE3

The purpose of this study is to compare the early onset of effect of Symbic...

Status

Completed

Location

Multiple Locations

Start Date

2003-04

Trial ID

NCT00646620

Treatments Being Tested

budesonide/formoterol (Symbicort)fluticasone/salmeterol (Advair Diskus)albuterol (Ventolin)

A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)

PHASE2

To evaluate the dose-response of different doses of CHF 1531 pressurized me...

Status

Completed

Location

Chiesi Investigational Site

Start Date

2017-09-08

Trial ID

NCT03086460

Treatments Being Tested

CHF 1531 pMDI Formoterol Inhalation Solution Placebo pMDI

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

PHASE2

The aim of this exploratory investigation is to evaluate if the Forced Expi...

Status

Completed

Location

Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Street Medical Centre

Start Date

2008-02

Trial ID

NCT01343745

Treatments Being Tested

BDP/formoterol BDP/formoterol Placebo

Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients

PHASE1

The study is performed to investigate the effect of the spacing device on t...

Status

Completed

Location

Medical University in Lodz

Start Date

2014-03

Trial ID

NCT02119234

Treatments Being Tested

Beclometasone/formoterol/glycopyrrolate Placebo

Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

PHASE1

This study will be carried out in healthy volunteers with the primary objec...

Status

Completed

Location

Clinical Pharmacology Unit - SGS Life Science Services

Start Date

2011-05

Trial ID

NCT01398111

Treatments Being Tested

Glycopyrrolate + Formoterol Glycopyrrolate Formoterol Placebo

Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®

PHASE1

The study is being conducted to compare the pharmacokinetic (PK) of BDP (an...

Status

Completed

Location

SGS Belgium NV - Clinical Pharmacology Unit

Start Date

2023-04-24

Trial ID

NCT05898984

Treatments Being Tested

Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI Reference product 1 (R1): CHF 5993 BDP/FF/GB 100/6/12.5 µg pMDI Reference product 2 (R2): BDP HFA (QVAR REDIHALER®, BDP 80 μg)

Previous Next